Analyses of MeRIP-seq, mRNA-seq, and databases have identified LHPP and NKX3–1 as the main targets of YTHDF2, and both LHPP and NKX3–1 are tumor suppressors that regulate tumor progression by inhibiting AKT phosphorylation [133–136]. The gene discussed is LHPP; the disease is neoplasm.